These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 17452490

  • 1. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
    Bugatti A, Urbinati C, Ravelli C, De Clercq E, Liekens S, Rusnati M.
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
    [Abstract] [Full Text] [Related]

  • 2. BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular Tat.
    Bugatti A, Chiodelli P, Rosenbluh J, Loyter A, Rusnati M.
    Antiviral Res; 2010 Jul; 87(1):30-9. PubMed ID: 20398703
    [Abstract] [Full Text] [Related]

  • 3. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
    Rusnati M, Taraboletti G, Urbinati C, Tulipano G, Giuliani R, Molinari-Tosatti MP, Sennino B, Giacca M, Tyagi M, Albini A, Noonan D, Giavazzi R, Presta M.
    FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
    Price TO, Ercal N, Nakaoke R, Banks WA.
    Brain Res; 2005 May 31; 1045(1-2):57-63. PubMed ID: 15910762
    [Abstract] [Full Text] [Related]

  • 5. The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry.
    Cardaci S, Soster M, Bussolino F, Marchiò S.
    FEBS Lett; 2013 Sep 17; 587(18):2943-51. PubMed ID: 23916815
    [Abstract] [Full Text] [Related]

  • 6. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
    Rusnati M, Coltrini D, Oreste P, Zoppetti G, Albini A, Noonan D, d'Adda di Fagagna F, Giacca M, Presta M.
    J Biol Chem; 1997 Apr 25; 272(17):11313-20. PubMed ID: 9111037
    [Abstract] [Full Text] [Related]

  • 7. The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.
    Rusnati M, Tulipano G, Urbinati C, Tanghetti E, Giuliani R, Giacca M, Ciomei M, Corallini A, Presta M.
    J Biol Chem; 1998 Jun 26; 273(26):16027-37. PubMed ID: 9632653
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein.
    Marchiò S, Alfano M, Primo L, Gramaglia D, Butini L, Gennero L, De Vivo E, Arap W, Giacca M, Pasqualini R, Bussolino F.
    Blood; 2005 Apr 01; 105(7):2802-11. PubMed ID: 15591114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-Tat and anti-HIV activities of trimers of n-alkylglycines.
    Márquez N, Sancho R, Macho A, Moure A, Masip I, Messeguer A, Muñoz E.
    Biochem Pharmacol; 2006 Feb 28; 71(5):596-604. PubMed ID: 16405868
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
    Urbinati C, Bugatti A, Oreste P, Zoppetti G, Waltenberger J, Mitola S, Ribatti D, Presta M, Rusnati M.
    FEBS Lett; 2004 Jun 18; 568(1-3):171-7. PubMed ID: 15196942
    [Abstract] [Full Text] [Related]

  • 15. alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells.
    Urbinati C, Bugatti A, Giacca M, Schlaepfer D, Presta M, Rusnati M.
    J Cell Sci; 2005 Sep 01; 118(Pt 17):3949-58. PubMed ID: 16105876
    [Abstract] [Full Text] [Related]

  • 16. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine.
    Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD.
    Ann Neurol; 2000 Feb 01; 47(2):186-94. PubMed ID: 10665489
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.
    Westendorp MO, Frank R, Ochsenbauer C, Stricker K, Dhein J, Walczak H, Debatin KM, Krammer PH.
    Nature; 1995 Jun 08; 375(6531):497-500. PubMed ID: 7539892
    [Abstract] [Full Text] [Related]

  • 19. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.
    Unwalla H, Chakraborti S, Sood V, Gupta N, Banerjea AC.
    Antiviral Res; 2006 Nov 08; 72(2):134-44. PubMed ID: 16790281
    [Abstract] [Full Text] [Related]

  • 20. Trans-dominant Tat mutants with alterations in the basic domain inhibit HIV-1 gene expression.
    Modesti N, Garcia J, Debouck C, Peterlin M, Gaynor R.
    New Biol; 1991 Aug 08; 3(8):759-68. PubMed ID: 1931822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.